Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase I... by Yoshifumi Kadono, Hiroyuki Konaka, Kouji Izumi, Satoshi Anai, Kiyohide Fujimoto, Kei Ishibashi, Noriyasu Kawai, Taku Kato, Akinori Iba, Naoya Masumori, Kenichi Yoshimura, Atsushiu Mizokami

Get full text